These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

262 related articles for article (PubMed ID: 23360500)

  • 21. Infection of dendritic cells (DCs), not DC-SIGN-mediated internalization of human immunodeficiency virus, is required for long-term transfer of virus to T cells.
    Burleigh L; Lozach PY; Schiffer C; Staropoli I; Pezo V; Porrot F; Canque B; Virelizier JL; Arenzana-Seisdedos F; Amara A
    J Virol; 2006 Mar; 80(6):2949-57. PubMed ID: 16501104
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Facile access to pseudo-thio-1,2-dimannoside, a new glycomimetic DC-SIGN antagonist.
    Tamburrini A; Achilli S; Vasile F; Sattin S; Vivès C; Colombo C; Fieschi F; Bernardi A
    Bioorg Med Chem; 2017 Oct; 25(19):5142-5147. PubMed ID: 28389114
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Monovalent mannose-based DC-SIGN antagonists: targeting the hydrophobic groove of the receptor.
    Tomašić T; Hajšek D; Švajger U; Luzar J; Obermajer N; Petit-Haertlein I; Fieschi F; Anderluh M
    Eur J Med Chem; 2014 Mar; 75():308-26. PubMed ID: 24556146
    [TBL] [Abstract][Full Text] [Related]  

  • 24. High and low affinity carbohydrate ligands revealed for murine SIGN-R1 by carbohydrate array and cell binding approaches, and differing specificities for SIGN-R3 and langerin.
    Galustian C; Park CG; Chai W; Kiso M; Bruening SA; Kang YS; Steinman RM; Feizi T
    Int Immunol; 2004 Jun; 16(6):853-66. PubMed ID: 15136555
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Lentivirus-mediated RNA interference of DC-SIGN expression inhibits human immunodeficiency virus transmission from dendritic cells to T cells.
    Arrighi JF; Pion M; Wiznerowicz M; Geijtenbeek TB; Garcia E; Abraham S; Leuba F; Dutoit V; Ducrey-Rundquist O; van Kooyk Y; Trono D; Piguet V
    J Virol; 2004 Oct; 78(20):10848-55. PubMed ID: 15452205
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Mannose glycoconjugates functionalized at positions 1 and 6. Binding analysis to DC-SIGN using biosensors.
    Reina JJ; Maldonado OS; Tabarani G; Fieschi F; Rojo J
    Bioconjug Chem; 2007; 18(3):963-9. PubMed ID: 17348701
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Second generation of fucose-based DC-SIGN ligands: affinity improvement and specificity versus Langerin.
    Andreini M; Doknic D; Sutkeviciute I; Reina JJ; Duan J; Chabrol E; Thepaut M; Moroni E; Doro F; Belvisi L; Weiser J; Rojo J; Fieschi F; Bernardi A
    Org Biomol Chem; 2011 Aug; 9(16):5778-86. PubMed ID: 21735039
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Distinct roles for DC-SIGN+-dendritic cells and Langerhans cells in HIV-1 transmission.
    de Witte L; Nabatov A; Geijtenbeek TB
    Trends Mol Med; 2008 Jan; 14(1):12-9. PubMed ID: 18055263
    [TBL] [Abstract][Full Text] [Related]  

  • 29. DC-SIGN (dendritic cell-specific ICAM-grabbing non-integrin) and DC-SIGN-related (DC-SIGNR): friend or foe?
    Soilleux EJ
    Clin Sci (Lond); 2003 Apr; 104(4):437-46. PubMed ID: 12653690
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Structural characterization of the DC-SIGN-Lewis(X) complex.
    Pederson K; Mitchell DA; Prestegard JH
    Biochemistry; 2014 Sep; 53(35):5700-9. PubMed ID: 25121780
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Development of C-type lectin-oriented surfaces for high avidity glycoconjugates: towards mimicking multivalent interactions on the cell surface.
    Porkolab V; Pifferi C; Sutkeviciute I; Ordanini S; Taouai M; Thépaut M; Vivès C; Benazza M; Bernardi A; Renaudet O; Fieschi F
    Org Biomol Chem; 2020 Jul; 18(25):4763-4772. PubMed ID: 32608454
    [TBL] [Abstract][Full Text] [Related]  

  • 32. DC-SIGN mediates binding of dendritic cells to authentic pseudo-LewisY glycolipids of Schistosoma mansoni cercariae, the first parasite-specific ligand of DC-SIGN.
    Meyer S; van Liempt E; Imberty A; van Kooyk Y; Geyer H; Geyer R; van Die I
    J Biol Chem; 2005 Nov; 280(45):37349-59. PubMed ID: 16155001
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Pseudo-Mannosylated DC-SIGN Ligands as Immunomodulants.
    Berzi A; Ordanini S; Joosten B; Trabattoni D; Cambi A; Bernardi A; Clerici M
    Sci Rep; 2016 Oct; 6():35373. PubMed ID: 27734954
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Gold manno-glyconanoparticles for intervening in HIV gp120 carbohydrate-mediated processes.
    Di Gianvincenzo P; Chiodo F; Marradi M; Penadés S
    Methods Enzymol; 2012; 509():21-40. PubMed ID: 22568899
    [TBL] [Abstract][Full Text] [Related]  

  • 35. C-type lectin Mermaid inhibits dendritic cell mediated HIV-1 transmission to CD4+ T cells.
    Nabatov AA; de Jong MA; de Witte L; Bulgheresi S; Geijtenbeek TB
    Virology; 2008 Sep; 378(2):323-8. PubMed ID: 18597806
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Hepatitis C virus targets DC-SIGN and L-SIGN to escape lysosomal degradation.
    Ludwig IS; Lekkerkerker AN; Depla E; Bosman F; Musters RJ; Depraetere S; van Kooyk Y; Geijtenbeek TB
    J Virol; 2004 Aug; 78(15):8322-32. PubMed ID: 15254204
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Molecular basis of the differences in binding properties of the highly related C-type lectins DC-SIGN and L-SIGN to Lewis X trisaccharide and Schistosoma mansoni egg antigens.
    Van Liempt E; Imberty A; Bank CM; Van Vliet SJ; Van Kooyk Y; Geijtenbeek TB; Van Die I
    J Biol Chem; 2004 Aug; 279(32):33161-7. PubMed ID: 15184372
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Characterization of DC-SIGN/R interaction with human immunodeficiency virus type 1 gp120 and ICAM molecules favors the receptor's role as an antigen-capturing rather than an adhesion receptor.
    Snyder GA; Ford J; Torabi-Parizi P; Arthos JA; Schuck P; Colonna M; Sun PD
    J Virol; 2005 Apr; 79(8):4589-98. PubMed ID: 15795245
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Designing nanomolar antagonists of DC-SIGN-mediated HIV infection: ligand presentation using molecular rods.
    Ordanini S; Varga N; Porkolab V; Thépaut M; Belvisi L; Bertaglia A; Palmioli A; Berzi A; Trabattoni D; Clerici M; Fieschi F; Bernardi A
    Chem Commun (Camb); 2015 Mar; 51(18):3816-9. PubMed ID: 25648900
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cellular uptake of gold nanoparticles bearing HIV gp120 oligomannosides.
    Arnáiz B; Martínez-Ávila O; Falcon-Perez JM; Penadés S
    Bioconjug Chem; 2012 Apr; 23(4):814-25. PubMed ID: 22433013
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.